MedPath

Hainan Shuangcheng Pharmaceuticals Co.,Ltd

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

FDA:2

Drug Approvals

Eptifibatide

Approval Date
Apr 21, 2022
FDA

Bivalirudin

Approval Date
Jun 20, 2019
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.